- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- January 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 280 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 379 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 371 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- April 2025
- 182 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1344EUR$1,500USD£1,145GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1791EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1120EUR$1,250USD£954GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1120EUR$1,250USD£954GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1791EUR$2,000USD£1,527GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1344EUR$1,500USD£1,145GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1120EUR$1,250USD£954GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1344EUR$1,500USD£1,145GBP
- Report
- February 2025
- 185 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- December 2024
- 59 Pages
Global
From €3578EUR$3,995USD£3,050GBP
- Report
- December 2024
Global
From €6718EUR$7,500USD£5,726GBP
- Report
- September 2024
- 112 Pages
Global
From €3583EUR$4,000USD£3,054GBP
- Report
- June 2025
- 50 Pages
Global
From €2374EUR$2,650USD£2,023GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more